Barakol
Barakol is an anticancer and anxiolytic agent identified in Cassia siamea. Barakol inhibits MMP-3 activity and enhances the cytotoxicity and antimetastatic effects of Doxorubicin (HY-15142) against cancer cells. Barakol induces apoptosis via reactive oxygen species (ROS) production, upregulation of the Bax/Bcl-2 protein ratio, and activation of caspase-9. Barakol exerts anxiolytic activity with diazepam-like effects, increases spontaneous longitudinal smooth muscle contraction of rat ileum in a concentration-dependent manner (EC50 = 0.3 mM), and inhibits norepinephrine-induced contraction suppression. Barakol can be used in research related to anxiety, intestinal motility, and neuroblastoma.
For research use only. We do not sell to patients.
- CAS No.: 24506-68-1
- Formula: C13H12O4
- Molecular Weight:232.23
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| P19 | IC50 |
1.5 mM
|
Reduction of mouse embryonal carcinoma P19 cell viability incubated for 24 hrs by XTT assay.
Reduction of mouse embryonal carcinoma P19 cell viability incubated for 24 hrs by XTT assay.
|
21777666 |
| MRC5 | IC50 |
2.3449 μM
|
Exhibits minimal cytotoxicity against MRC-5 normal embryonic lung cells.
Exhibits minimal cytotoxicity against MRC-5 normal embryonic lung cells.
|
38318050 |
In Vitro
Barakol (0.05-4 mM; 12-24 h) reduces the viability of P19 cells in a concentration- and time-dependent manner, with an IC50 of 1.5 mM, and impairs mitochondrial function[1].
Barakol (0.2-1.5 mM; 24 h) induces concentration-dependent apoptosis in P19 cells, leading to apoptosis in approximately 30% of cells, and this effect is attenuated by pretreatment with 1 mM NAC (HY-B0215)[1].
Barakol (0.4-1.5 mM; 9 h) reduces Bcl-2 protein expression in a concentration-dependent manner, upregulates the Bax/Bcl2 ratio in P19 cells, and this effect is reversed by pretreatment with NAC[1].
Barakol (0.2-1.5 mM; 24 h) activates caspase-9 in P19 cells in a concentration-dependent manner in vitro with a treatment duration of 24 h[1].
Barakol (0.4 mM; 15-360 min) induces rapid and transient intracellular ROS production in P19 cells, with ROS levels peaking at 2 h; hydroxyl radicals represent the main ROS driving this reaction, and this effect is completely blocked by pretreatment with 1 mM NAC[1].
Barakol (0.0043-43.0 μM; 8 h pretreatment; 24 h incubation with or without Doxorubicin) enhances the cytotoxic effect of low-dose Doxorubicin (HY-15142A) on human neuroblastoma SH-SY5Y cells, while it itself exhibits only extremely low cytotoxicity at doses up to 4.3 μM; it also significantly reduces intracellular ROS levels in human neuroblastoma SH-SY5Y cells, with a more pronounced effect at higher Doxorubicin doses[2].
Barakol (0.043-43.0 μM; 24 h) inhibits MMP-3 activity in human SH-SY5Y neuroblastoma cells at the concentration of 43.0 μM after 24 h of incubation[2].
Barakol (0.043-43.0 μM; 12-36 h) inhibits the migration of human neuroblastoma SH-SY5Y cells in a dose- and time-dependent manner[2].
Barakol (0.043-43.0 μM; 10-60 min) inhibits the activity of MMP-3 in a time- and dose-dependent manner[2].
Barakol (48 h) exhibits extremely low cytotoxicity against MRC-5 normal embryonic lung cells, with an IC50 of 2.3449 μM[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:mouse embryonal carcinoma P19 cells
-
Concentration:0.2, 0.4 and 1.5 mM (24 h incubation); 1.5 mM (with 1 mM NAC pretreatment)
-
Incubation Time:24 h (0.2-1.5 mM); 30 min (NAC pretreatment) followed by 24 h (1.5 mM)
-
Result:Induced concentration-dependent apoptotic morphological changes (condensed chromatin, apoptotic bodies) in P19 cells.
Induced apoptosis in approximately 30% of cells at 1.5 mM for 24 h.
Significantly inhibited apoptosis induced by 1.5 mM when pretreated with 1 mM NAC.
-
Cell Line:mouse embryonal carcinoma P19 cells
-
Concentration:0.4 and 1.5 mM (9 h incubation); 1.5 mM (with 1 mM NAC pretreatment)
-
Incubation Time:9 h (0.4-1.5 mM); 30 min (NAC pretreatment) followed by 9 h (1.5 mM)
-
Result:Caused a concentration-dependent reduction in Bcl-2 protein expression, while Bax protein expression remained unchanged compared to controls, resulting in a significant increase in the Bax/Bcl-2 ratio.
Reversed the barakol-induced reduction in Bcl-2 expression and normalized the Bax/Bcl-2 ratio when pretreated with 1 mM NAC.
-
Cell Line:SH-SY5Y human neuroblastoma cells
-
Concentration:0.0043, 0.043, 0.43, 4.3 and 43.0 μM
-
Incubation Time:8 h pretreatment; 24 h incubation with or without doxorubicin
-
Result:Showed no significant effect on cell viability at all tested doses except 43.0 μM.
Significantly enhanced the cytotoxic effect of low-dose doxorubicin (0.5 or 1.0 μM) at all tested concentrations, reducing cell viability compared to control, doxorubicin alone, or barakol alone.
-
Cell Line:SH-SY5Y human neuroblastoma cells
-
Concentration:0.043, 0.43, 4.3, and 43.0 μM
-
Incubation Time:12, 24, and 36 h
-
Result:Significantly inhibited cell migration at 43.0 μM after 24 h.
Significantly inhibited cell migration at 0.43 and 4.3 μM after 36 h.
Increased inhibitory effect with higher concentrations and longer incubation times.
In Vivo
Barakol (10 mg/kg; i.p.; single administration) produces an anxiolytic effect profile similar to that of the benzodiazepine anxiolytic Diazepam in the elevated plus maze test, but also increases exploratory behavior and spontaneous activity, and this effect is partially inhibited by co-administration of the anxiolytic Diazepam[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Wistar (male, 150-170 g)[3]
-
Dosage:10 mg/kg; 25 mg/kg; 50 mg/kg; 75 mg/kg
-
Administration:i.p.; single dose
-
Result:Significantly increased all measured parameters (percentage of open:total number of arm entries and time, time spent on the end of the open arms, total arm entries, and rears per minute) compared to control at 10 mg/kg.
Increased the percentage of open:total number of arm entries and time, and significantly increased rears per minute compared to control at 25 and 50 mg/kg; these parameters were significantly reduced compared to the 10 mg/kg dose, and had no significant effect on time spent on the end of open arms or total arm entries compared to control, with these parameters also significantly reduced compared to the 10 mg/kg dose.
Significantly reduced all measured parameters compared to the 10 mg/kg dose at 75 mg/kg.
-
Animal Model:Wistar (male, 150-170 g)[3]
-
Dosage:10 mg/kg
-
Administration:i.p.; single dose
-
Result:Significantly increased all measured parameters (percentage of open:total number of arm entries and time, time spent on the end of the open arms, total arm entries, and rears per minute) compared to control, unlike benzodiazepine anxiolytic agent which did not increase total arm entries or rears.
Produced a behavioural profile matching barakol alone for most parameters when benzodiazepine anxiolytic agent was administered 30 minutes before barakol, except for a marked reduction in the number of rears compared to barakol alone, and a significant increase in total arm entries compared to benzodiazepine anxiolytic agent alone.
Chemical Information
-
CAS No. 24506-68-1
-
Molecular Weight 232.23
-
Formula C13H12O4
-
SMILES
OC1=CC2=C3C(OC(C)=CC(OC(C)=C2)3O)=C1
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Mitochondrial membrane-potential fluorescent assay
Mitochondrial membrane potential fluorescent assays estimate ΔΨm in living cells using lipophilic cationic dyes such as TMRM, TMRE, rhodamine 123, and JC-1, which accumulate in mitochondria according to membrane polarization; loss of signal after FCCP or CCCP treatment is interpreted as mitochondrial depolarization. TMRM/TMRE and rhodamine 123 are commonly used for semi-quantitative live-cell microscopy or flow cytometry, while JC-1 can report a shift from red aggregate fluorescence to green monomer fluorescence during depolarization; interpretation requires controls because dye concentration, quenching mode, cell type, dye efflux, and mitochondrial mass can affect fluorescence independently of ΔΨm.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Protocol for Elevated Plus Maze Test
The Elevated Plus Maze is a rodent anxiety-like behavior assay based on the conflict between spontaneous exploration and avoidance of open, elevated, exposed spaces. The apparatus contains two open arms and two closed arms arranged in a plus shape, and rodents normally spend more time in closed arms than open arms. The assay readout is generated by recording arm entries, time spent in open and closed arms, and related exploratory behaviors. Increased open-arm time or open-arm entries is commonly interpreted as reduced anxiety-like behavior, whereas reduced open-arm exploration is interpreted as increased anxiety-like behavior.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
[1]. Wongtongtair S, et al. Barakol-induced apoptosis in P19 cells through generation of reactive oxygen species and activation of caspase-9. Journal of ethnopharmacology. 2011 Sep 02;137(2):971-8. [Content Brief]
[2]. Wongsawatkul O, et al. Effects of barakol from Cassia siamea on neuroblastoma SH-SY5Y cell line: A potential combined therapy with doxorubicin. Heliyon. 2024 Jan 19;10(3):e24694. [Content Brief]
[3]. Thongsaard W, et al. Barakol: a potential anxiolytic extracted from Cassia siamea. Pharmacology, biochemistry, and behavior. 1996 Mar;53(3):753-8. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)